Department of Biochemistry, University of Kerala, Kariavattom Campus, Thiruvananthapuram, Kerala 695581, India.
Comb Chem High Throughput Screen. 2022;25(10):1661-1671. doi: 10.2174/1386207324666210302101204.
The management of acute inflammation, which arises from complex biological responses to harmful stimuli, is an important determinant in the recovery from an otherwise detrimental outcome such as septicemia. However, the side effects and limitations of current therapeutics necessitate the development of newer and safer alternatives. Mollugo cerviana is a common medicinal herb of the Indian subcontinent and has been traditionally used for its fever mitigating anti-microbial and hepatoprotective action. We have already reported the rich presence of radical scavenging phytochemicals in the plant extracts and their strong antioxidant properties.
In the present study, we have evaluated the anti-inflammatory effects of methanolic extract (ME) of the areal parts of M. cerviana in a lipopolysaccharide (LPS)-induced acute inflammatory cell culture model.
RAW 264.7 mouse macrophage cells were stimulated by the bacterial endotoxin LPS at a concentration of 1 μg/mL. Cytotoxicity and anti-inflammatory potential of ME were carried out.
The concentration of M. cerviana extract up to 150 μg/ml was found to be non-toxic to cells (MTT and NRU assay). LPS induces acute inflammation by binding to TLR-4 receptors, initiating a downstream signalling cascade that results in pro-inflammatory cytokine secretion. Extract treatment at 100 μg/ml suppressed LPS-induced gene expression (qPCR) and secretion (ELISA) of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α, and the chemokine CCL2, leading to dampening of the acute inflammatory cascade. LPS-induced elevation of ROS level (DCFDA method) was significantly reduced by extract treatment. Nitric oxide production, as indicated by nitrite level, was significantly reduced post extract treatment.
This study demonstrated that M. cerviana methanolic extract has a potent antiinflammatory effect in the in vitro acute inflammation model of LPS-stimulated RAW 264.7 cells. There is no reported study so far on the anti-inflammatory properties of M. cerviana in an LPSinduced acute inflammatory model, which closely mimics a human bacteremia response. Hence, this study highlights the therapeutic potential of this extract as a source of anti-inflammatory lead molecules.
急性炎症的治疗是一个复杂的生物学过程,需要针对有害刺激物做出反应,这是从败血症等有害后果中恢复的重要决定因素。然而,当前治疗方法的副作用和局限性需要开发更新、更安全的替代方法。牛膝菊是印度次大陆常见的药用草本植物,传统上用于缓解发热、具有抗菌和保肝作用。我们已经报道了该植物提取物中丰富的自由基清除植物化学物质的存在及其强大的抗氧化特性。
本研究评估了牛膝菊地上部分甲醇提取物(ME)在脂多糖(LPS)诱导的急性炎症细胞培养模型中的抗炎作用。
用细菌内毒素 LPS(浓度为 1μg/ml)刺激 RAW 264.7 小鼠巨噬细胞。进行 ME 的细胞毒性和抗炎潜力检测。
在 MTT 和 NRU 测定中,发现牛膝菊提取物的浓度高达 150μg/ml 时对细胞无毒。LPS 通过与 TLR-4 受体结合诱导急性炎症,启动下游信号级联反应,导致促炎细胞因子的分泌。在 100μg/ml 浓度下,提取物可抑制 LPS 诱导的促炎细胞因子(qPCR 和 ELISA)IL-1β、IL-6 和 TNF-α以及趋化因子 CCL2 的基因表达和分泌,从而抑制急性炎症级联反应。提取物处理可显著降低 LPS 诱导的 ROS 水平(DCFDA 法)。提取物处理后,亚硝酸盐水平指示的一氧化氮产生显著减少。
本研究表明,牛膝菊甲醇提取物在 LPS 刺激的 RAW 264.7 细胞体外急性炎症模型中具有强大的抗炎作用。目前还没有关于牛膝菊在 LPS 诱导的急性炎症模型中的抗炎特性的报道,该模型更接近人类菌血症反应。因此,这项研究强调了该提取物作为抗炎先导分子的治疗潜力。